New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

FDA's rising criticism: A response option

With an expanded staff and power, FDA 483 letters are expected to rise. Here's one option on how to avoid and respond to agency criticism.

Hp 19185 I Stock Warning And Risk

CEE Packaging, the Packaging Industry of Central and Eastern Europe, reports that a 10-step guide is available to help pharmaceutical processors, medical device manufacturers, and other life-sciences facilities respond appropriately within the permitted 15-day window of receiving a 483 letter from the agency. The guide, “How to Avoid and Respond to Public FDA Criticisms—Form 483 Letters—for Temperature, Humidity and other Controlled Environments,” comes from Veriteq.

CGMP.com provides some basics on FDA-issued warning letters.

Packaging World/Healthcare Packaging legal columnist Eric Greenberg recently discussed the agency's increasing activity. Read more about FDA, regulatory, and legal developments.

-Jim Butschli, Editor

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts
How to Honor a Leader
Induction into the Packaging & Processing Hall of Fame is the highest honor in our industry. Submit your leader to be considered for the Class of 2024 now through June 10th. New members will be inducted at PACK EXPO International in Chicago.
Read More
How to Honor a Leader